Boston Scientific (BSX) Free Cash Flow (2009 - 2026)

Boston Scientific's Free Cash Flow history runs 18 years deep, the most recent figure standing at $171.0 million for Q1 2026.

• In Q1 2026, Free Cash Flow fell 51.69% year-over-year to $171.0 million; the TTM figure through Mar 2026 stood at $3.5 billion (up 15.3% YoY), while the FY2025 annual figure was $3.7 billion, up 38.3% from the prior year.
• Free Cash Flow came in at $171.0 million for Q1 2026 at Boston Scientific, down from $1.0 billion in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $1.2 billion in Q4 2024 to a low of -$179.0 million in Q1 2022.
• A 5-year average of $541.4 million and a median of $515.0 million in 2023 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow plunged 185.65% in 2022 and jumped 2460.0% in 2025, its largest moves.
• Boston Scientific's Free Cash Flow stood at $595.0 million in 2022, then advanced by 15.97% to $690.0 million in 2023, then soared by 70.87% to $1.2 billion in 2024, then dropped by 14.08% to $1.0 billion in 2025, then tumbled by 83.12% to $171.0 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered $171.0 million, $1.0 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison